Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent
about
Extinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesisStructure and functionality in flavivirus NS-proteins: perspectives for drug designRibavirin as an anti-cancer therapy: acute myeloid leukemia and beyond?RNA virus error catastrophe: direct molecular test by using ribavirinT-705 (favipiravir) inhibition of arenavirus replication in cell cultureEvaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic feverSynergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenavirusesRibavirin Reveals a Lethal Threshold of Allowable Mutation Frequency for Hantaan VirusA new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivoCrystal structure of Tritrichomonas foetus inosine monophosphate dehydrogenase in complex with the inhibitor ribavirin monophosphate reveals a catalysis-dependent ion-binding siteApproved Antiviral Drugs over the Past 50 YearsThe Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug DesignMutagenic Effects of Ribavirin on Hepatitis E Virus-Viral Extinction versus Selection of Fitness-Enhancing MutationsCompounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virusCompounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: Influenza life-cycle and currently available drugsAntiviral activities of ribavirin, 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide, and 6'-(R)-6'-C-methylneplanocin A against several ortho- and paramyxovirusesAntiviral activity of 3-deazaguanine, 3-deazaguanosine, and 3-deazaguanylic acidAntiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compoundsInhibitory effects of antiviral compounds on respiratory syncytial virus replication in vitroRibavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitroEffects of selenazofurin and ribavirin and their 5'-triphosphates on replicative functions of influenza A and B virusesVaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infectionsComparative inhibition of influenza and parainfluenza virus replication by ribavirin in MDCK cellsInhibition of rotaviruses by selected antiviral substances: mechanisms of viral inhibition and in vivo activityThe synthesis and antiviral activity of 4-fluoro-1-beta-D-ribofuranosyl-1H-pyrazole-3-carboxamideCoronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeuticsChemotherapeuticsDrugs in development for influenza.Combination chemotherapy for influenza.T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitroSensitive radioimmunoassay for the broad-spectrum antiviral agent ribavirinNovel treatments for recurrent respiratory papillomatosis.Antiviral activity of ribavirin in rotavirus gastroenteritis of mice.Antiviral activity of a small-molecule inhibitor of filovirus infectionEffects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in mice.Approaches and strategies for the treatment of influenza virus infections.Ribavirin resistance in hepatitis C virus replicon-containing cell lines conferred by changes in the cell line or mutations in the replicon RNA.Inhibition of lymphocyte proliferative responses by ribavirin.Recent advances in diagnosis and therapy of human papillomaviruses.Neuroprotection and reduced proliferation of microglia in ribavirin-treated bornavirus-infected rats.
P2860
Q21132564-FE021149-A050-467B-ACFC-56F8832B399CQ23011530-FF07672E-2D77-482F-9AE2-F88D42694E7DQ24594939-00563CF0-5AFD-4D75-A022-2C2ECC88E946Q24599371-3DA55470-523E-4A51-84CB-8F594A85F9CFQ24633241-99E68250-1B1C-43F2-90D3-D3EB54F48995Q27457152-0D20F208-F9E0-47FF-AF0B-8F041CD6D3FBQ27478091-BC8EC8C9-257F-4460-B6AC-3D642C209A9DQ27484998-CEDEB4A8-E816-4D3E-A8D3-3B3D62E7C62CQ27490484-963EDE21-D7A7-42B6-B744-2E74501D1C48Q27639659-B1DAB189-96C7-42B4-B9CF-CAECE81A18B2Q27755387-D2B18F6C-E2E0-4696-B230-4996ED88F5D8Q28071809-3CBB4F8D-B67E-45B9-A8EE-ABA53CCA75DBQ28072953-CE45A359-DD65-4CE5-BA81-1A7BC801BFA7Q28084005-68F96A87-DBB1-4CCB-AB0D-10AADD3A3BBFQ28085400-B78FA618-6A82-4ADA-AC20-4E717115F4CEQ28320242-B5FF5064-0A9E-4460-BFF5-EB64B2B6095EQ28321316-F1DB6B2F-7B6A-4773-ADF8-8EF7C74F2C2CQ28328538-4B19A600-B760-42CE-A39F-BFE14F31D0A3Q28361333-924F765F-302E-4069-B8F7-B81F2A33FF03Q28361577-49D9CDD1-8FBB-4B5B-A427-AA333AB2BC66Q28362058-105B3326-0EBB-47A5-B5CA-6B790ACAAADBQ28362129-FB11C653-7A2A-4F3E-967A-2F17D373D726Q28366120-0D620D08-DBA5-4751-9269-17D931C010BDQ28366158-5411B7B2-CE73-4C0F-AC9B-BD96636567D3Q28370843-0F784EF7-6A12-4066-8FC1-A7E0DA77D6C1Q28535361-E1307C17-3700-4D7D-A01C-79325162C074Q30047670-48220075-135F-4D66-BA9F-16A6349FFF8AQ30391218-F6B2B64D-20E1-4B02-9257-645E020DC576Q30408112-B9AF422B-0C3C-4E0E-9F87-4BA8F0FF2AD1Q30426020-2E2ED50D-AB70-42F6-95BC-7FCE1A181848Q30451335-C9B3A374-BC1D-49CA-BAF5-6F0A7AECBED2Q31099594-667791A8-9785-44B5-993E-65C3BC068FCFQ31932958-18B86F96-8BCE-4414-94AC-0077930143E1Q33538454-DCAB38E6-60D7-4919-A060-046BC38FB152Q33559151-B30EFE5C-5CE5-454E-9D40-C9AA83E87601Q33730165-2071FF07-0F3B-4DEF-9B1D-90C2859EBEA9Q33782525-46DAC80D-B8FC-461C-B517-3AED4A498670Q33906667-A8104D61-6CBE-434B-9247-879DC6ABA51EQ34074998-371F4A50-41D3-47CB-8DC9-DCDCA0CD75ACQ34109709-6E29DB18-449C-4951-A29F-D2154901F52B
P2860
Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent
description
1973 nî lūn-bûn
@nan
1973 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1973 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1973年の論文
@ja
1973年論文
@yue
1973年論文
@zh-hant
1973年論文
@zh-hk
1973年論文
@zh-mo
1973年論文
@zh-tw
1973年论文
@wuu
name
Mechanism of action of 1- -D-r ...... broad-spectrum antiviral agent
@ast
Mechanism of action of 1- -D-r ...... broad-spectrum antiviral agent
@en
type
label
Mechanism of action of 1- -D-r ...... broad-spectrum antiviral agent
@ast
Mechanism of action of 1- -D-r ...... broad-spectrum antiviral agent
@en
prefLabel
Mechanism of action of 1- -D-r ...... broad-spectrum antiviral agent
@ast
Mechanism of action of 1- -D-r ...... broad-spectrum antiviral agent
@en
P2093
P2860
P356
P1476
Mechanism of action of 1- -D-r ...... broad-spectrum antiviral agent
@en
P2093
Sidwell RW
Streeter DG
Witkowski JT
P2860
P304
P356
10.1073/PNAS.70.4.1174
P407
P577
1973-04-01T00:00:00Z